ArticleHistoria, ciencias, saude--Manguinhos2024
The "pharmakon" of prevention: artificial immunity in the covid-19 pandemic.
Article in Historia, ciencias, saude--Manguinhos, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The concept of pharmakon encapsulates the paradoxical ambivalence of any therapeutic intervention's harmful as well as beneficial effects; within the context of immunological practices related to covid-19, this ambivalence has been successfully exploited by anti-vaccination movements and is also evident in widespread vaccine hesitancy in wealthy countries where vaccines for this virus are widely available. Here we engage with the theoretical apparatus of the pharmakon to examine how care, harm, risk, and prevention are enacted in covid-19 prevention measures and mobilize the transdisciplinary methodologies of science and technology studies to investigate how anticipatory imaginaries drive cutting-edge research on covid-19 vaccines and the clinical and social practices they have elicited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.